A rare diagnosis changes everything. You weren’t given a playbook on how to cope, how to take that next step, and you certainly weren’t handed a blueprint on how to build an advocacy organization and successfully bring a therapy to market.
Join market access and commercialization executives from pharmaceutical and biotech companies with a focus on rare, genetic, and orphan diseases to explore the current commercial dynamics surrounding these unique products.
Rare Diseases and Orphan Products Breakthrough Summit NORD’s Rare Diseases and Orphan Products Breakthrough Summit is the largest and most meaningful multi-stakeholder event of its kind – historically featuring over...
Pharmaceutical and biotech companies all believe in representing the patient voice within the company.
The World Orphan Drug Congress is entering into its 7th year in November 2016. The Congress was one of the first events to bring together the full range of stakeholders...
Genetic Rx will take place at Harvard Medical School and will bring together academics, key industry leaders and investors to discuss the emergence of new genetic medicines as well as...
The RARE Patient Advocacy Summit is the can’t-miss event of the year for rare disease stakeholders. The Summit will take place October 3-4 at the Hotel Irvine in Irvine, California,...
On Wednesday, April 10, 2019, Engage Health will host a workshop on Identifying and Engaging Patients and Clinicians in the Rare Disease Space as part of the World Orphan Drug...
On Wednesday, April 10, 2019, MME and LapidusData will host a workshop on Predicting and Influencing the Market Potential of Orphan Drugs and Gene Therapies as part of the World Orphan...
RARE COLLECTIVE® is a trademark of Rare Collective, LLC. 